Background: There is an urgent need for a reliable in vitro system that can accurately replicate the cardiac physiological environment for drug testing. The limited availability of human heart tissue culture systems has led to inaccurate interpretations of cardiac related drug effects. Our group had previously developed a culture system for pig/human heart slices that enables functional and structural viability for 6 days under electric stimulation and enriched media and can reliably demonstrate the subacute toxic effects of anti-cancer therapeutics. However, by day 10, the slices undergo cardiomyocyte dedifferentiation and fibrotic remodeling, making them inadequate for long-term drug testing.Aims: To determine whether including physiological mechanical and humoral cues within the culture system can prolong the viability of the heart tissue in culture.Methods and Results: We have developed a novel cardiac tissue culture model (CTCM) that can electro-mechanically stimulate heart slices with physiological preload and afterload during each cardiac cycle. After 12 days in culture, this approach was able to partially improve the viability of heart slices, but not to completely maintain their structural integrity. Therefore, following small molecule screening, we found that incorporation of 100 nM tri-iodo-thyronine (T3) and 1 μM dexamethasone (Dex) into our culture media preserved microscopic structure of the slices for 12 days. When combined with T3/Dex treatment, the CTCM system was able to maintain the transcriptional profile, viability, metabolic activity, and structure integrity for 12 days at the same levels as the fresh heart tissue. Furthermore, overstretching the cardiac tissue induced cardiac hypertrophy after 6 days in culture, which provides the first proof of concept for the ability of the CTCM to emulate cardiac pathophysiology. Conclusions: This manuscript describes a new physiological culture system for heart slices that incorporates physiological mechanical and humoral cues for maintaining viability and functionality of the heart slices. The CTCM has the potential to emulate cardiac physiology and pathophysiology in culture for extended period of time, thereby enabling reliable drug screening.